Eric G. Spokas

690 total citations
22 papers, 550 citations indexed

About

Eric G. Spokas is a scholar working on Molecular Biology, Pharmacology and Biochemistry. According to data from OpenAlex, Eric G. Spokas has authored 22 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Pharmacology and 5 papers in Biochemistry. Recurrent topics in Eric G. Spokas's work include Eicosanoids and Hypertension Pharmacology (5 papers), Inflammatory mediators and NSAID effects (5 papers) and Nitric Oxide and Endothelin Effects (3 papers). Eric G. Spokas is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (5 papers), Inflammatory mediators and NSAID effects (5 papers) and Nitric Oxide and Endothelin Effects (3 papers). Eric G. Spokas collaborates with scholars based in United States and New Zealand. Eric G. Spokas's co-authors include Patrick Y.-K. Wong, Giancarlo Folco, King-Teh Lin, Jiyan Xue, Marie C. Lin, Frank F. Sun, Giuseppe Pugliese, E Marcinkiewicz, R D Levere and Kevin Mullane and has published in prestigious journals such as Journal of Biological Chemistry, Environmental Science & Technology and Blood.

In The Last Decade

Eric G. Spokas

22 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric G. Spokas United States 11 195 134 121 95 89 22 550
C.M. Ingerman-Wojenski United States 9 113 0.6× 104 0.8× 95 0.8× 135 1.4× 202 2.3× 12 578
P. V. Halushka United States 12 134 0.7× 133 1.0× 192 1.6× 177 1.9× 105 1.2× 27 672
Roma A. Armstrong United Kingdom 13 165 0.8× 97 0.7× 201 1.7× 272 2.9× 152 1.7× 18 644
Clara Santonastaso Italy 11 106 0.5× 79 0.6× 104 0.9× 83 0.9× 199 2.2× 16 646
C Lechi Italy 16 151 0.8× 91 0.7× 122 1.0× 140 1.5× 231 2.6× 45 657
Ferhana Y. Ali United Kingdom 8 119 0.6× 79 0.6× 224 1.9× 115 1.2× 224 2.5× 8 647
Josée Sraer France 12 99 0.5× 102 0.8× 190 1.6× 108 1.1× 71 0.8× 18 461
F. B. Ubatuba United Kingdom 10 80 0.4× 161 1.2× 145 1.2× 202 2.1× 141 1.6× 15 573
Dilinaer Bolati Japan 9 134 0.7× 55 0.4× 284 2.3× 58 0.6× 50 0.6× 10 760
B.A. Nassar United Kingdom 12 103 0.5× 123 0.9× 133 1.1× 67 0.7× 31 0.3× 28 524

Countries citing papers authored by Eric G. Spokas

Since Specialization
Citations

This map shows the geographic impact of Eric G. Spokas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric G. Spokas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric G. Spokas more than expected).

Fields of papers citing papers by Eric G. Spokas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric G. Spokas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric G. Spokas. The network helps show where Eric G. Spokas may publish in the future.

Co-authorship network of co-authors of Eric G. Spokas

This figure shows the co-authorship network connecting the top 25 collaborators of Eric G. Spokas. A scholar is included among the top collaborators of Eric G. Spokas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric G. Spokas. Eric G. Spokas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spokas, Eric G., et al.. (2008). Release of the lipid peroxidation marker 8-epi-prostaglandin F2α from isolated gill pavement cells. Environmental Toxicology and Chemistry. 27(7). 1569–1575. 2 indexed citations
2.
Spokas, Eric G., Bernd W. Spur, Holly W. Smith, Francis W. Kemp, & John D. Bogden. (2006). Tissue Lead Concentration during Chronic Exposure of Pimephales promelas (Fathead Minnow) to Lead Nitrate in Aquarium Water. Environmental Science & Technology. 40(21). 6852–6858. 16 indexed citations
3.
Cohen, Glenn M., Chen Jiang, & Eric G. Spokas. (2006). Alkaline and Acid Phosphatase Activities in the Mosquitofish Gill. Microscopy and Microanalysis. 12(S02). 250–251. 1 indexed citations
4.
Spokas, Eric G., Joshua Rokach, & Patrick Y.-K. Wong. (2003). Leukotrienes, Lipoxins, and Hydroxyeicosatetraenoic Acids. Humana Press eBooks. 120. 213–247. 9 indexed citations
5.
Spokas, Eric G., M D Crivellone, Francis W. Kemp, John D. Bogden, & Glenn M. Cohen. (2002). Characterization of Sodium, Potassium, ATPase Activity in the Gills of Pimephales promelas (Fathead Minnow): Influence of In Vitro Exposure to Lead. Bulletin of Environmental Contamination and Toxicology. 69(3). 384–392. 3 indexed citations
6.
Spokas, Eric G. & Bernd W. Spur. (2001). Rapid Measurement of Low Levels of Sodium, Potassium-ATPase Activity by Ascorbic Acid Reduction without Strong Acid. Analytical Biochemistry. 299(1). 112–116. 7 indexed citations
7.
Liu, Peitan, et al.. (2000). Role of Endogenous Nitric Oxide in TNF-α and IL-1β Generation in Hepatic Ischemia-Reperfusion. Shock. 13(3). 217–223. 54 indexed citations
8.
Lin, King-Teh, Henry P. Godfrey, Eric G. Spokas, Frank F. Sun, & Patrick Y.-K. Wong. (1999). Modulation of LTB4 Receptor in T-Lymphocytes by Lipoxin A4 (LXA4) and Its Role in Delayed-Type Hypersensitivity. Advances in experimental medicine and biology. 447. 151–163. 1 indexed citations
9.
Lin, King-Teh, Jiyan Xue, Marie C. Lin, et al.. (1998). Peroxynitrite induces apoptosis of HL-60 cells by activation of a caspase-3 family protease. American Journal of Physiology-Cell Physiology. 274(4). C855–C860. 85 indexed citations
10.
Wong, Patrick Y.-K., Grace Gar‐Lee Yue, Kai Yin, et al.. (1997). Anti-P-Selectin Antibody Exacerbated Inflammatory Responses in Acetic Acid-Induced Colitis. Advances in experimental medicine and biology. 433. 323–326. 2 indexed citations
11.
Spokas, Eric G. & Tze-Chein Wun. (1992). Venous thrombosis produced in the vena cava of rabbits by vascular damage and stasis. Journal of Pharmacological and Toxicological Methods. 27(4). 225–232. 21 indexed citations
12.
13.
14.
Spokas, Eric G., et al.. (1987). Cardiovascular effects of chronic high-dose atriopeptin III infusion in normotensive rats. Toxicology and Applied Pharmacology. 91(3). 305–314. 4 indexed citations
15.
Pugliese, Giuseppe, Eric G. Spokas, E Marcinkiewicz, & Patrick Y.-K. Wong. (1985). Hepatic transformation of prostaglandin D2 to a new prostanoid, 9 alpha,11 beta-prostaglandin F2, that inhibits platelet aggregation and constricts blood vessels.. Journal of Biological Chemistry. 260(27). 14621–14625. 53 indexed citations
16.
Spokas, Eric G. & Giancarlo Folco. (1984). Intima-related vasodilatation of the perfused rat caudal artery. European Journal of Pharmacology. 100(2). 211–217. 31 indexed citations
17.
Spokas, Eric G., Giancarlo Folco, John Quilley, Praveen Chander, & J C McGiff. (1983). Endothelial mechanism in the vascular action of hydralazine.. Hypertension. 5(2_pt_2). I107–11. 47 indexed citations
18.
Miller, Mark J.S., Eric G. Spokas, & John C. McGiff. (1982). Metabolism of prostaglandin E2 in the isolated perfused kidney of the rabbit. Biochemical Pharmacology. 31(18). 2955–2960. 9 indexed citations
19.
Spokas, Eric G., Patrick Y.-K. Wong, & J C McGiff. (1982). Prostaglandin-related renin release from rabbit renal cortical slices.. Hypertension. 4(3_pt_2). 96–100. 9 indexed citations
20.
Spokas, Eric G., et al.. (1980). Regional blood flow and cardiac responses to hydralazine.. Journal of Pharmacology and Experimental Therapeutics. 212(2). 294–303. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026